AuntMinnie

SEPTEMBER 13, 2023

The Medical Imaging and Technology Alliance (MITA) has raised concerns ove. Read more on AuntMinnie.com Related Reading: ACR urges full coverage for amyloid PET scans CMS proposal covers PET scans for Alzheimer’s disease MITA praises FDA for Leqembi approval FIND Act reintroduced in U.S.

Radiopharmaceuticals 52

Radiopharmaceuticals PET Scan Disease Medical Imaging 52

Imaging Technology

AUGUST 29, 2023

Alan Taylor , stated, “Large-scale manufacture of therapeutic Cu-67 from highly efficient, environmentally preferable electron accelerators is critical to overcome the widespread supply issues in the radiopharmaceutical industry, due to a heavy reliance on a small number of antiquated nuclear reactors.

Pharmaceutical 75

Pharmaceutical Radiopharmaceuticals Clinic Medical 75

Future Teleradiology

NOVEMBER 27, 2023

This blog post sheds light on recent breakthroughs in nuclear medicine, illuminating the innovative advancements that are shaping the future of medical imaging and treatment. Discuss how these advancements enhance imaging capabilities, providing clearer insights into physiological processes.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Modalities Radiation 52

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 63

Medical Radiopharmaceuticals Pharmaceutical Radiation 63

Imaging Technology

OCTOBER 5, 2023

Specifically, this sub-group examined the performance of flotufolastat F 18 PET in newly diagnosed, high-risk prostate cancer patients who had negative results with conventional imaging. Kuo, MD, Ph.D. , Departments of Medical Imaging, Medicine, and Biomedical Engineering. Recently approved by the U.S. on behalf of Gary A.

Diagnose 52

Diagnose Diagnostic Disease Radiation 52

Imaging Technology

SEPTEMBER 27, 2023

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. “PET Departments of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona, Tucson, Ariz.,

Diagnostic 93

Diagnostic Radiation Oncology Radiation Clinic 93

Imaging Technology

APRIL 3, 2023

NorthStar’s industry-leading reputation is grounded in technological innovation, successful execution and proven expertise, and we have made tremendous strides in advancing our portfolio over the past year,” said Stephen Merrick , Chief Executive Officer of NorthStar Medical Radioisotopes.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82